☆ 4.6 Letter

BNIP3L in myelodysplastic syndromes and acute myeloid leukemia: impact on disease outcome and cellular response to decitabine

HAEMATOLOGICA (2016)

Journal

HAEMATOLOGICA

Volume 101, Issue 11, Pages E445-E448

Publisher

FERRATA STORTI FOUNDATION

DOI: 10.3324/haematol.2016.142521

Keywords

Funding

Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq/MCT)
Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
Fundacao de Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6

Not enough ratings

BNIP3L in myelodysplastic syndromes and acute myeloid leukemia: impact on disease outcome and cellular response to decitabine

Journal

HAEMATOLOGICA

Publisher

FERRATA STORTI FOUNDATION

Keywords

Categories

Funding

Ask authors/readers for more resources

Protocol

Reagent

Authors

I am an author on this paper

Reviews

Primary Rating

Secondary Ratings

Novelty

Significance

Scientific rigor

Rate this paper

Recommended

BNIP3L in myelodysplastic syndromes and acute myeloid leukemia: impact on disease outcome and cellular response to decitabine

Journal

HAEMATOLOGICA

Publisher

FERRATA STORTI FOUNDATION

Keywords

Categories

Funding

Ask authors/readers for more resources

Protocol

Reagent

Authors

I am an author on this paper

Reviews

Primary Rating

Secondary Ratings

Novelty

Significance

Scientific rigor

Rate this paper

Recommended

Export Citation

Share Paper